中文名 | N-Boc-4-(4-氯苯基)-4-哌啶羧酸 |
---|---|
英文名 | 4-(4-chlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carboxylic acid |
英文别名 |
4-(4-Chlorophenyl)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarboxylic acid
1,4-Piperidinedicarboxylic acid, 4-(4-chlorophenyl)-, 1-(1,1-dimethylethyl) ester |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 471.3±45.0 °C at 760 mmHg |
分子式 | C17H22ClNO4 |
分子量 | 339.814 |
闪点 | 238.9±28.7 °C |
精确质量 | 339.123749 |
PSA | 66.84000 |
LogP | 3.30 |
外观性状 | 固体 |
蒸汽压 | 0.0±1.2 mmHg at 25°C |
折射率 | 1.552 |
储存条件 | 室温 |
危害码 (欧洲) | Xn |
---|---|
海关编码 | 2933399090 |
~88% 644981-94-2 |
文献:Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Harriman, Geraldine C.B.; Carson, Kenneth G.; Ghosh, Shomir; Elder, Amy M.; Mattia, Karen M. Patent: US2005/70549 A1, 2005 ; |
~45% 644981-94-2 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2007/125321 A2, 2007 ; Location in patent: Page/Page column 132 ; WO 2007/125321 A2 |
~45% 644981-94-2 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2006/51290 A2, 2006 ; Location in patent: Page/Page column 147 ; WO 2006/051290 A2 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |